Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Erik Kuntze"'
Autor:
G Nicholson, D Makhija, Erik Kuntze, Josh Epstein, J S Price, Vikas V. Patel, S. Ikeme, M Rock
Publikováno v:
Journal of Medical Economics. 20:606-613
A recently published retrospective analysis comparing two different active flowable hemostatic matrices (FLOSEAL and SURGIFLO Kit with Thrombin) showed significantly increased resource use and complications (surgery time, risk of blood product transf
Publikováno v:
Hospital practice (1995). 46(4)
Flowable agents such as Floseal® (F) are often reserved as adjuncts to non-flowable agents (i.e. gelatin (G) sponges and thrombin (T)) when bleeding is not sufficiently controlled. Based on their perceived positive impact, it is postulated that flow
Publikováno v:
Expert review of medical devices. 15(5)
Intraoperative surgical sealants and hemostatic agents have been shown to reduce postoperative complications, transfusions, and hospital resource utilization. Despite availability of these agents, the incidence and burden of bleeding remains high and
Autor:
Erik Kuntze, Daniela Cianciulli, Luca Weltert, S. Ikeme, Josh Epstein, Gerhard Bothma, Kevin M. Lewis, Nicole Pay
Publikováno v:
Journal of medical economics. 21(3)
A recent randomized controlled trial showed that patients undergoing ascending aorta surgery treated with HEMOPATCH to control bleeding had a significantly better hemostasis success rate than with dry or wet gauze compression or similar standard of c
Publikováno v:
Value in Health. 20:A609
Publikováno v:
Medical Devices (Auckland, N.Z.)
The need for advanced hemostatic agents increases with the complexity of surgical procedures and use of anticoagulation and antiplatelet treatments. HEMOPATCH (Sealing Hemostat) is a novel, advanced hemostatic pad that is composed of a synthetic, pro
Publikováno v:
The American journal of geriatric pharmacotherapy. 4(2)
Objective: The aim of this study was to compare the safety profile of atorvastatin calcium at 4 doses with that of placebo in elderly patients (age, ≥65 years). Methods: A single pooled database (Pfizer Atorvastatin Clinical Program Database) of 50
Publikováno v:
Journal of Clinical Lipidology. 1:164
Publikováno v:
Value in Health. (2):161-169
Objectives To evaluate whether intensive statin therapy in a managed-care setting produces greater clinical benefit than more moderate statin use. Methods Adults hospitalized for a coronary heart disease (CHD) event were identified from a longitudina